Antibodies Assay Kits Biology Cells Brd4 Antibody Muc2 Antibody NATtrol Nedd4 Antibody Nox1 Antibody Panel Particles PCR Pcr Kits Peptides Vector & Virus Vi Alpha Vitronectin Antibody Western Blot Zebrafish Antibodies
Glycolysis-related gene expression profiling serves as a novel prognosis risk predictor for human hepatocellular carcinoma
Metabolic sample reconstruction is a vital think about tumor development. Metabolism of tumor cells is characterised by irregular enhance in anaerobic glycolysis, no matter excessive oxygen focus, leading to a major accumulation of power from glucose sources.
These adjustments promotes speedy cell proliferation and tumor development, which is additional referenced a course of generally known as the Warburg impact. The present examine reconstructed the metabolic sample in development of most cancers to determine genetic adjustments particular in most cancers cells. A complete of 12 widespread kinds of stable tumors have been included within the present examine.
Gene set enrichment evaluation (GSEA) was carried out to research 9 glycolysis-related gene units, that are implicated within the glycolysis course of. Univariate and multivariate analyses have been used to determine unbiased prognostic variables for building of a nomogram based mostly on clinicopathological traits and a glycolysis-related gene prognostic index (GRGPI).
The prognostic mannequin based mostly on glycolysis genes confirmed excessive space beneath the curve (AUC) in LIHC (Liver hepatocellular carcinoma). The findings of the present examine confirmed that eight genes (AURKA, CDK1, CENPA, DEPDC1, HMMR, KIF20A, PFKFB4, STMN1) have been correlated with total survival (OS) and recurrence-free survival (RFS).
Additional evaluation confirmed that the prediction mannequin precisely distinguished between high- and low-risk most cancers sufferers amongst sufferers in several clusters in LIHC. A nomogram with a well-fitted calibration curve based mostly on gene expression profiles and medical traits confirmed good discrimination based mostly on inner and exterior cohorts. These findings point out that adjustments in expression degree of metabolic genes implicated in glycolysis can contribute to reconstruction of tumor-related microenvironment.
Modifications in Methylation Patterns of Tumor Suppressor Genes throughout Prolonged Human Embryonic Stem Cell Cultures
Whereas research on embryonic stem cells have been actively carried out, little is understood in regards to the epigenetic mechanisms in human embryonic stem cells (hESCs) in prolonged tradition methods. Right here, we investigated whether or not CpG island (CGI) methylation patterns of 24 tumor suppressor genes could possibly be maintained throughout prolonged hESC cultures. In complete, 10 hESC strains have been analyzed.
For every cell line, genomic DNA was extracted from early and late passages of cell cultures. CGI methylation ranges of 24 tumor suppressor genes have been analyzed utilizing methylation-specific multiplex ligation-dependent probe amplification (MS-MLPA), pyrosequencing, and real-time polymerase chain response (PCR). Totally different CGI methylation patterns of CASP8, FHIT, and CHFR genes have been recognized in between early and late passages in some hESC strains.
CGI methylation ranges of CASP8 considerably elevated at late passage in CHA-36, CHA-40, and CHA-42 cell strains in comparison with these at early passage. The CGI methylation of the FHIT gene was greater at late passage than at early passage in CHA-15, CHA-31, CHA-32, and iPS (FS)-1 cell strains however decreased on the late passage in CHA-20 and H1 cell strains.
Totally different CGI methylation patterns have been detected for the CHFR gene solely in iPS (FS)-1, and the extent considerably elevated at late passage. Thus, our findings present that CGI methylation patterns could possibly be altered throughout extended ESC cultures and analyzing these epigenetic adjustments is vital to evaluate the upkeep, differentiation, and medical utilization of stem cells.
A genetic danger rating utilizing human chromosomal-scale size variation can predict schizophrenia
Research point out that schizophrenia has a genetic part, nevertheless it can’t be remoted to a single gene. We aimed to find out how nicely one might predict that an individual will develop schizophrenia based mostly on their germ line genetics. We in contrast 1129 folks from the UK Biobank dataset who had a prognosis of schizophrenia to an equal variety of age matched folks drawn from the overall UK Biobank inhabitants.
For every particular person, we constructed a profile consisting of numbers. Every quantity characterised the size of segments of chromosomes. We examined a number of machine studying algorithms to find out which was simplest in predicting schizophrenia and if any enchancment in prediction happens by breaking the chromosomes into smaller chunks.
We discovered that the stacked ensemble, carried out greatest with an space beneath the receiver working attribute curve (AUC) of 0.545 (95% CI 0.539-0.550). We famous a rise within the AUC by breaking the chromosomes into smaller chunks for evaluation. Utilizing SHAP values, we recognized the X chromosome as a very powerful contributor to the predictive mannequin. We conclude that germ line chromosomal scale size variation knowledge might present an efficient genetic danger rating for schizophrenia which performs higher than probability.
Clinically important findings of high-risk mutations in human SLC29A4 gene related to diabetes mellitus kind 2 in Pakistani inhabitants
This examine carried out an in-depth evaluation combining computational and experimental verifications of the deleterious missense mutations related to the SLC29A4 protein. The purposeful annotation of the non-synonymous single nucleotide polymorphism (nsSNPs), adopted by structure-function evaluation, revealed 13 single nucleotide polymorphisms (SNP) as probably the most damaging.
Amongst these, six mutants P429T/S, L144S, M108V, N86H, and V79E, have been predicted as structurally and functionally damaging by protein stability evaluation. Additionally, these variants are situated at evolutionary conserved areas, both buried, contributing to the structural injury, or uncovered, inflicting purposeful adjustments within the protein.
These mutants have been additional taken for molecular docking research. When verified by way of experimental evaluation, the SNPs M108V (rs149798710), N86H (rs151039853), and V79E (rs17854505) confirmed an affiliation with kind 2 diabetes mellitus (T2DM). Minor allele frequency for rs149798710 (A > G) was 0.23 in controls, 0.29 in metformin responders, 0.37 in metformin non-responder, for rs151039853 (A > C) was 0.21 in controls, 0.28 in metformin responders, 0.36 in metformin non-responder and for rs17854505 (T > A) was 0.20 in controls, 0.25 in metformin responders, 0.37 in metformin non-responder.
Recombinant YFV Genome polyprotein (NS4A) Protein (aa 1-3412) |
|||
VAng-Cr6545-inquire | Creative Biolabs | inquire | Ask for price |
Description: YFV (isolate Uganda/A7094A4/1948) Genome polyprotein (NS4A), recombinant protein. |
Recombinant Hepatitis C Genome polyprotein |
|||
CSB-RP184674Ba | Cusabio | 5430 mg | Ask for price |
Recombinant Hepatitis C Genome polyprotein |
|||
RPC24458-100ug | Biomatik Corporation | 100ug | EUR 721.6 |
Recombinant Hepatitis C Genome polyprotein |
|||
RPC24458-20ug | Biomatik Corporation | 20ug | EUR 448.1 |
Recombinant Zika virus Genome polyprotein, partial |
|||
CSB-EP3643GOZ3 | Cusabio | 7769 mg | Ask for price |
Recombinant Human parechovirus 1 Genome polyprotein |
|||
CSB-YP734409HCAV | Cusabio | 9748 mg | Ask for price |
Recombinant Enterovirus A71 Genome polyprotein, partial |
|||
CSB-EP3114GLA | Cusabio | 7385 mg | Ask for price |
Recombinant Enterovirus A71 Genome polyprotein, partial |
|||
CSB-EP3114GLAa2 | Cusabio | 7384 mg | Ask for price |
Recombinant Enterovirus A71 Genome polyprotein, partial |
|||
CSB-EP3114GLAe0 | Cusabio | 7511 mg | Ask for price |
Recombinant Enterovirus A71 Genome polyprotein, partial |
|||
CSB-EP3114GLAe1 | Cusabio | 7917 mg | Ask for price |
Recombinant Enterovirus A71 Genome polyprotein,partial |
|||
RPC28548-100ug | Biomatik Corporation | 100ug | EUR 801.9 |
Recombinant Enterovirus A71 Genome polyprotein,partial |
|||
RPC28548-1mg | Biomatik Corporation | 1mg | EUR 2885.2 |
Recombinant Enterovirus A71 Genome polyprotein,partial |
|||
RPC28548-20ug | Biomatik Corporation | 20ug | EUR 448.1 |
Recombinant Enterovirus A71 Genome polyprotein,partial |
|||
RPC28549-100ug | Biomatik Corporation | 100ug | EUR 801.9 |
Recombinant Enterovirus A71 Genome polyprotein,partial |
|||
RPC28549-1mg | Biomatik Corporation | 1mg | EUR 2885.2 |
Recombinant Enterovirus A71 Genome polyprotein,partial |
|||
RPC28549-20ug | Biomatik Corporation | 20ug | EUR 448.1 |
Recombinant Human Genome polyprotein, His, Yeast-1mg |
|||
QP7370-ye-1mg | EnQuireBio | 1mg | EUR 2262 |
Recombinant Human Genome polyprotein, His, Yeast-10ug |
|||
QP7370-ye-10ug | EnQuireBio | 10ug | EUR 283.2 |
Recombinant Human Genome polyprotein, His, Yeast-50ug |
|||
QP7370-ye-50ug | EnQuireBio | 50ug | EUR 358.8 |
Recombinant Coxsackievirus B3 Genome polyprotein, partial |
|||
CSB-EP361017CRM1 | Cusabio | 8884 mg | Ask for price |
Recombinant West Nile virus Genome polyprotein, partial |
|||
CSB-EP356974WAF2 | Cusabio | 9323 mg | Ask for price |
Recombinant Human Genome polyprotein, His, Yeast-100ug |
|||
QP7370-ye-100ug | EnQuireBio | 100ug | EUR 576 |
Recombinant Human Genome polyprotein, His, Yeast-200ug |
|||
QP7370-ye-200ug | EnQuireBio | 200ug | EUR 892.8 |
Recombinant Human Genome polyprotein, His, Yeast-500ug |
|||
QP7370-ye-500ug | EnQuireBio | 500ug | EUR 1447.2 |
Recombinant Hepatitis C virus Genome polyprotein,partial |
|||
AP72393 | SAB | each | Ask for price |
Recombinant Yellow fever virus Genome polyprotein,partial |
|||
AP77947 | SAB | 1mg | EUR 2826 |
Recombinant Yellow fever virus Genome polyprotein, partial |
|||
CSB-EP365905YAC1 | Cusabio | 3485 mg | Ask for price |
Recombinant Yellow fever virus Genome polyprotein,partial |
|||
RPC22821-100ug | Biomatik Corporation | 100ug | EUR 721.6 |
Recombinant Yellow fever virus Genome polyprotein,partial |
|||
RPC22821-1mg | Biomatik Corporation | 1mg | EUR 2884.7 |
Recombinant Yellow fever virus Genome polyprotein,partial |
|||
RPC22821-20ug | Biomatik Corporation | 20ug | EUR 448.1 |
Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
CSB-YP326367HQA | Cusabio | 6222 mg | Ask for price |
Recombinant Human rhinovirus 1A Genome polyprotein,partial |
|||
AP72911 | SAB | each | Ask for price |
Recombinant Human rhinovirus 1A Genome polyprotein, partial |
|||
CSB-EP326367HQA | Cusabio | 11613 mg | Ask for price |
Recombinant Human rhinovirus 1B Genome polyprotein, partial |
|||
CSB-EP320160HQB | Cusabio | 10401 mg | Ask for price |
Recombinant Human rhinovirus 1A Genome polyprotein,partial |
|||
RPC25135-100ug | Biomatik Corporation | 100ug | EUR 573.1 |
Recombinant Human rhinovirus 1A Genome polyprotein,partial |
|||
RPC25135-20ug | Biomatik Corporation | 20ug | EUR 288.8 |
Recombinant Human Genome polyprotein, His-SUMO, E.coli-1mg |
|||
QP7370-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |
Recombinant Human parechovirus 2 Genome polyprotein, partial |
|||
CSB-EP529147HXJ | Cusabio | 9583 mg | Ask for price |
Recombinant Human parechovirus 1 Genome polyprotein, partial |
|||
CSB-EP734409HCAV | Cusabio | 9651 mg | Ask for price |
Recombinant Dengue virus type 2 Genome polyprotein, partial |
|||
CSB-YP530838DCF | Cusabio | 7267 mg | Ask for price |
Recombinant Human Genome polyprotein, His-SUMO, E.coli-10ug |
|||
QP7370-ec-10ug | EnQuireBio | 10ug | EUR 240 |
Recombinant Human Genome polyprotein, His-SUMO, E.coli-50ug |
|||
QP7370-ec-50ug | EnQuireBio | 50ug | EUR 315.6 |
Recombinant Human Genome polyprotein, His-SUMO, E.coli-100ug |
|||
QP7370-ec-100ug | EnQuireBio | 100ug | EUR 489.6 |
Recombinant Human Genome polyprotein, His-SUMO, E.coli-200ug |
|||
QP7370-ec-200ug | EnQuireBio | 200ug | EUR 760.8 |
Recombinant Human Genome polyprotein, His-SUMO, E.coli-500ug |
|||
QP7370-ec-500ug | EnQuireBio | 500ug | EUR 1272 |
Recombinant Japanese encephalitis virus Genome polyprotein, partial |
|||
CSB-EP189574Ba | Cusabio | 2537 mg | Ask for price |
Recombinant Bovine viral diarrhea virus Genome polyprotein , partial |
|||
CSB-YP312464BKX1 | Cusabio | 6140 mg | Ask for price |
Recombinant Classical swine fever virus Genome polyprotein, partial |
|||
CSB-YP4953GLU | Cusabio | 12085 mg | Ask for price |
Recombinant Bovine viral diarrhea virus Genome polyprotein, partial |
|||
CSB-BP312464BKX1 | Cusabio | 139 mg | Ask for price |
Recombinant Classical swine fever virus Genome polyprotein, partial |
|||
CSB-BP4334GLU | Cusabio | 10139 mg | Ask for price |
Recombinant St. louis encephalitis virus Genome polyprotein, partial |
|||
CSB-EP357746SKT | Cusabio | 9322 mg | Ask for price |
Recombinant Classical swine fever virus Genome polyprotein, partial |
|||
CSB-EP4953GLU | Cusabio | 11663 mg | Ask for price |
Recombinant Bovine viral diarrhea virus Genome polyprotein, partial |
|||
CSB-EP312464BKX1 | Cusabio | 2704 mg | Ask for price |
Recombinant Bovine viral diarrhea virus Genome polyprotein,partial |
|||
RPC28130-100ug | Biomatik Corporation | 100ug | EUR 1544.5 |
Recombinant Bovine viral diarrhea virus Genome polyprotein,partial |
|||
RPC28130-20ug | Biomatik Corporation | 20ug | EUR 580.8 |
Recombinant Dengue virus type 2 Genome polyprotein (Q1642N), partial |
|||
CSB-EP3044GLD(M) | Cusabio | 11736 mg | Ask for price |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
CSB-YP530838HVQ(A3) | Cusabio | 6465 mg | Ask for price |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein, partial |
|||
CSB-YP530838HVQ(A4) | Cusabio | 6466 mg | Ask for price |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial |
|||
AP73727 | SAB | each | Ask for price |
Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial |
|||
AP73728 | SAB | each | Ask for price |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|||
CSB-EP333180HFD | Cusabio | 3004 mg | Ask for price |
Recombinant Hepatitis C virus genotype 1a Genome polyprotein, partial |
|||
CSB-MP333180HFD | Cusabio | 4998 mg | Ask for price |
Recombinant Tick-borne encephalitis virus Genome polyprotein, partial |
|||
CSB-EP3056GKR | Cusabio | 2646 mg | Ask for price |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial |
|||
CSB-YP362073HQD | Cusabio | 6387 mg | Ask for price |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial |
|||
AP71163 | SAB | 1mg | EUR 1978 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial |
|||
AP72984 | SAB | each | Ask for price |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial |
|||
AP77542 | SAB | 1mg | EUR 1978 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial |
|||
CSB-EP362073HQD | Cusabio | 3389 mg | Ask for price |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial |
|||
CSB-EP362073HQDb0 | Cusabio | 3390 mg | Ask for price |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial |
|||
RPC22779-100ug | Biomatik Corporation | 100ug | EUR 460.9 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial |
|||
RPC22779-1mg | Biomatik Corporation | 1mg | EUR 2237.8 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial |
|||
RPC22779-20ug | Biomatik Corporation | 20ug | EUR 258.7 |
Recombinant Human parechovirus 2 Genome polyprotein, partial, Biotinylated |
|||
CSB-EP897051HHAL-B | Cusabio | 10843 mg | Ask for price |
Recombinant Human parechovirus 1 Genome polyprotein, partial, Biotinylated |
|||
CSB-EP734409HCAV-B | Cusabio | 10800 mg | Ask for price |
Recombinant Dengue virus 2 Genome polyprotein (T2493G,G2494S,I2762T), partial |
|||
CSB-EP2239GLD(M) | Cusabio | 11735 mg | Ask for price |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein, partial, Biotinylated |
|||
CSB-EP362073HQD-B | Cusabio | 7058 mg | Ask for price |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial,Biotinylated |
|||
RPC27677-100ug | Biomatik Corporation | 100ug | EUR 614.3 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial,Biotinylated |
|||
RPC27677-1mg | Biomatik Corporation | 1mg | EUR 2373.6 |
Recombinant Human rhinovirus A serotype 89 Genome polyprotein,partial,Biotinylated |
|||
RPC27677-20ug | Biomatik Corporation | 20ug | EUR 468 |
Genome Polyprotein Antibody |
|||
20-abx109417 | Abbexa |
|
|
Genome polyprotein Antibody |
|||
20-abx300967 | Abbexa |
|
|
Genome polyprotein Antibody |
|||
1-CSB-PA18549A0Rb | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is Unconjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody |
|||
1-CSB-PA333180LA01HFD | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is Unconjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody |
|||
1-CSB-PA362073LA01HQD | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is Unconjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody |
|||
CSB-PA4643XA11GSV | Cusabio | 100ul / 50ul | EUR 299 |
Description: Genome polyprotein |
Genome polyprotein Antibody |
|||
CSB-PA4644XA11GSW | Cusabio | 100ul / 50ul | EUR 299 |
Description: Genome polyprotein |
Genome polyprotein Antibody |
|||
1-CSB-PA714772LA01HYH | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is Unconjugated. Tested in the following application: ELISA |
Genome Polyprotein Antibody |
|||
abx109417-100l | Abbexa | 100 µl | EUR 162.5 |
Genome polyprotein Antibody |
|||
abx300967-100g | Abbexa | 100 µg | EUR 362.5 |
Genome polyprotein Antibody |
|||
abx300967-20g | Abbexa | 20 µg | EUR 162.5 |
Genome polyprotein Antibody |
|||
abx300967-50g | Abbexa | 50 µg | EUR 250 |
Recombinant Tick-borne encephalitis virus European subtype Genome polyprotein, partial |
|||
CSB-EP318509TEM | Cusabio | 11863 mg | Ask for price |
Recombinant Hepatitis C virus genotype 1a (isolate 1) (HCV) Genome polyprotein(E1),partial |
|||
AP70969 | SAB | 1mg | EUR 2826 |
Recombinant Tick-borne encephalitis virus Far Eastern subtype Genome polyprotein, partial |
|||
CSB-EP357187TEN | Cusabio | 11862 mg | Ask for price |
Recombinant Tick-borne encephalitis virus Far Eastern subtype Genome polyprotein, partial |
|||
CSB-EP357187TENa0 | Cusabio | 11843 mg | Ask for price |
Recombinant Tick-borne encephalitis virus Far Eastern subtype Genome polyprotein, partial |
|||
CSB-EP357187TENc7 | Cusabio | 11839 mg | Ask for price |
Genome polyprotein Antibody (HRP) |
|||
20-abx109095 | Abbexa |
|
|
Genome polyprotein Antibody (HRP) |
|||
20-abx300968 | Abbexa |
|
|
Hepatitis C Genome polyprotein |
|||
1-CSB-RP184674Ba | Cusabio |
|
|
Description: Recombinant Hepatitis C Genome polyprotein expressed in E.coli |
Genome polyprotein Antibody (HRP) |
|||
abx109095-100l | Abbexa | 100 µl | EUR 162.5 |
Genome polyprotein Antibody (HRP) |
|||
abx300968-100g | Abbexa | 100 µg | EUR 362.5 |
Genome polyprotein Antibody (HRP) |
|||
abx300968-20g | Abbexa | 20 µg | EUR 162.5 |
Genome polyprotein Antibody (HRP) |
|||
abx300968-50g | Abbexa | 50 µg | EUR 250 |
Genome polyprotein Antibody (FITC) |
|||
20-abx107678 | Abbexa |
|
|
Genome polyprotein Antibody (FITC) |
|||
20-abx300969 | Abbexa |
|
|
Genome polyprotein Antibody (FITC) |
|||
abx107678-100g | Abbexa | 100 µg | EUR 362.5 |
Genome polyprotein Antibody (FITC) |
|||
abx107678-20g | Abbexa | 20 µg | EUR 162.5 |
Genome polyprotein Antibody (FITC) |
|||
abx107678-50g | Abbexa | 50 µg | EUR 250 |
Genome polyprotein Antibody (FITC) |
|||
abx300969-100g | Abbexa | 100 µg | EUR 362.5 |
Genome polyprotein Antibody (FITC) |
|||
abx300969-20g | Abbexa | 20 µg | EUR 162.5 |
Genome polyprotein Antibody (FITC) |
|||
abx300969-50g | Abbexa | 50 µg | EUR 250 |
Genome Polyprotein Antibody (Biotin) |
|||
20-abx105887 | Abbexa |
|
|
Genome polyprotein Antibody (Biotin) |
|||
20-abx106264 | Abbexa |
|
|
Genome polyprotein Antibody (Biotin) |
|||
20-abx300970 | Abbexa |
|
|
Genome Polyprotein Antibody (Biotin) |
|||
abx105887-100g | Abbexa | 100 µg | EUR 362.5 |
Genome Polyprotein Antibody (Biotin) |
|||
abx105887-20g | Abbexa | 20 µg | EUR 162.5 |
Genome Polyprotein Antibody (Biotin) |
|||
abx105887-50g | Abbexa | 50 µg | EUR 250 |
Genome polyprotein Antibody (Biotin) |
|||
abx106264-100g | Abbexa | 100 µg | EUR 362.5 |
Genome polyprotein Antibody (Biotin) |
|||
abx106264-20g | Abbexa | 20 µg | EUR 162.5 |
Genome polyprotein Antibody (Biotin) |
|||
abx106264-50g | Abbexa | 50 µg | EUR 250 |
Genome polyprotein Antibody (Biotin) |
|||
abx300970-100g | Abbexa | 100 µg | EUR 362.5 |
Genome polyprotein Antibody (Biotin) |
|||
abx300970-20g | Abbexa | 20 µg | EUR 162.5 |
Genome polyprotein Antibody (Biotin) |
|||
abx300970-50g | Abbexa | 50 µg | EUR 250 |
Genome Polyprotein Polyclonal Antibody |
|||
A68253 | EpiGentek |
|
|
Genome Polyprotein Polyclonal Antibody |
|||
A68254 | EpiGentek |
|
|
Genome Polyprotein Polyclonal Antibody |
|||
A56130 | EpiGentek |
|
|
Genome Polyprotein Polyclonal Antibody |
|||
A56743 | EpiGentek |
|
|
Yellow fever virus Genome polyprotein |
|||
1-CSB-EP365905YAC1 | Cusabio |
|
|
Description: Recombinant Yellow fever virus Genome polyprotein,partial expressed in E.coli |
Genome Polyprotein (HCV-Core) Antibody |
|||
33487-05111 | AssayPro | 150 ug | EUR 215 |
Human rhinovirus 1A Genome polyprotein |
|||
1-CSB-YP326367HQA | Cusabio |
|
|
Description: Recombinant Human rhinovirus 1A Genome polyprotein,partial expressed in Yeast |
Enterovirus 71 Genome polyprotein Antibody |
|||
20-abx109758 | Abbexa |
|
|
Genome polyprotein Antibody, HRP conjugated |
|||
1-CSB-PA18549B0Rb | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is HRP conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, HRP conjugated |
|||
1-CSB-PA333180LB01HFD | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is HRP conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, HRP conjugated |
|||
1-CSB-PA362073LB01HQD | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is HRP conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, HRP conjugated |
|||
1-CSB-PA714772LB01HYH | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is HRP conjugated. Tested in the following application: ELISA |
Enterovirus 71 Genome polyprotein Antibody |
|||
abx109758-100l | Abbexa | 100 µl | EUR 162.5 |
Genome polyprotein Antibody, FITC conjugated |
|||
1-CSB-PA18549C0Rb | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is FITC conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, FITC conjugated |
|||
1-CSB-PA333180LC01HFD | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is FITC conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, FITC conjugated |
|||
1-CSB-PA362073LC01HQD | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is FITC conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, FITC conjugated |
|||
1-CSB-PA714772LC01HYH | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is FITC conjugated. Tested in the following application: ELISA |
Classical Swine Fever Virus Genome Polyprotein (CSFV-GP) Protein |
|||
abx694331-10nmol | Abbexa | 10 nmol | EUR 625 |
Classical Swine Fever Virus Genome Polyprotein (CSFV-GP) Protein |
|||
abx694331-5nmol | Abbexa | 5 nmol | EUR 425 |
Genome polyprotein Antibody, Biotin conjugated |
|||
1-CSB-PA18549D0Rb | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Dengue virus. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, Biotin conjugated |
|||
1-CSB-PA333180LD01HFD | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Hepatitis C virus genotype 1a. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, Biotin conjugated |
|||
1-CSB-PA362073LD01HQD | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human rhinovirus A serotype 89. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Genome polyprotein Antibody, Biotin conjugated |
|||
1-CSB-PA714772LD01HYH | Cusabio |
|
|
Description: A polyclonal antibody against Genome polyprotein. Recognizes Genome polyprotein from Human enterovirus 71. This antibody is Biotin conjugated. Tested in the following application: ELISA |
Japanese encephalitis virus Genome polyprotein |
|||
1-CSB-EP189574Ba | Cusabio |
|
|
Description: Recombinant Japanese encephalitis virus Genome polyprotein,partial expressed in E.coli |
Enterovirus 71 Genome polyprotein Antibody (HRP) |
|||
20-abx108220 | Abbexa |
|
|
Enterovirus 71 Genome polyprotein Antibody (HRP) |
|||
abx108220-100g | Abbexa | 100 µg | EUR 362.5 |
Enterovirus 71 Genome polyprotein Antibody (HRP) |
|||
abx108220-20g | Abbexa | 20 µg | EUR 162.5 |
Enterovirus 71 Genome polyprotein Antibody (HRP) |
|||
abx108220-50g | Abbexa | 50 µg | EUR 250 |
Enterovirus 71 Genome polyprotein Antibody (FITC) |
|||
20-abx106801 | Abbexa |
|
|
Enterovirus 71 Genome polyprotein Antibody (FITC) |
|||
abx106801-100g | Abbexa | 100 µg | EUR 362.5 |
Enterovirus 71 Genome polyprotein Antibody (FITC) |
|||
abx106801-20g | Abbexa | 20 µg | EUR 162.5 |
Enterovirus 71 Genome polyprotein Antibody (FITC) |
|||
abx106801-50g | Abbexa | 50 µg | EUR 250 |
Anti-CrPV Genome polyprotein Polyclonal Antibody |
|||
AB1I144 | Antagene | 0.1mg | EUR 399 |
Enterovirus 71 Genome polyprotein Antibody (Biotin) |
|||
20-abx105382 | Abbexa |
|
|
Enterovirus 71 Genome polyprotein Antibody (Biotin) |
|||
abx105382-100g | Abbexa | 100 µg | EUR 362.5 |
Enterovirus 71 Genome polyprotein Antibody (Biotin) |
|||
abx105382-20g | Abbexa | 20 µg | EUR 162.5 |
Enterovirus 71 Genome polyprotein Antibody (Biotin) |
|||
abx105382-50g | Abbexa | 50 µg | EUR 250 |
Hepatitis C virus genotype 1b Genome polyprotein |
|||
1-CSB-YP530838HVQ(A3) | Cusabio |
|
|
Description: Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial expressed in Yeast |
Hepatitis C virus genotype 1b Genome polyprotein |
|||
1-CSB-YP530838HVQ(A4) | Cusabio |
|
|
Description: Recombinant Hepatitis C virus genotype 1b Genome polyprotein,partial expressed in Yeast |
Hepatitis C virus genotype 1a Genome polyprotein |
|||
1-CSB-EP333180HFD | Cusabio |
|
|
Description: Recombinant Hepatitis C virus genotype 1a Genome polyprotein,partial expressed in E.coli |
Hepatitis C virus genotype 1a Genome polyprotein |
|||
1-CSB-MP333180HFD | Cusabio |
|
|
Description: Recombinant Hepatitis C virus genotype 1a Genome polyprotein,partial expressed in Mammalian cell |
Porcine Teschovirus 1 Genome Polyprotein Antibody |
|||
abx345841-100g | Abbexa | 100 µg | Ask for price |
Porcine Teschovirus 1 Genome Polyprotein Antibody |
|||
abx345841-20g | Abbexa | 20 µg | EUR 250 |
×
Therefore, this examine concludes that SLC29A4 M108V (rs149798710), N86H (rs151039853), and V79E (rs17854505) polymorphisms have been related to the elevated danger of T2DM in addition to with the elevated danger in direction of the failure of metformin therapeutic response in T2DM sufferers of Pakistan. Communicated by Ramaswamy H. Sarma.
Tags: acetylated lysine antibody ago2 antibody amotl2 antibody anti np antibody bca protein assay kit bradford protein assay caspase 3 staining cell lysis buffer complete protease inhibitor cocktail culture vessel cxcr2 antibody dna quantification kit elisa plate reader elisa reader exosap it protocol fitc labeling genomic dna isolation kits human serum luria broth mesenchymal stem cell media mouse embryonic fibroblasts cell culture pbs buffer plasmid midi prep protein extraction kit qpcr sybr green rhoc antibody semidry transfer buffer streptavidin size sulfo nhs lc biotin western blotting apparatus zo-1 antibody